Prevention and control of noncommunicable diseases in Armenia: the case for investment
Other Titles
Abstract
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Armenia.This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 362.7 billion dram, equivalent to 6.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions.A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the tobacco policy package achieved a return of more than 14.5 dram over 15 years for every 1 dram invested, and for a salt reduction package the equivalent return on investment was more than 14.2 dram for every 1 dram invested.
Citation
Farrington, Jill, Kontsevaya, Anna, Fediaev, Denis, Grafton, Daniel, Khachatryan, Henrik et al. (2019). Prevention and control of noncommunicable diseases in Armenia: the case for investment. World Health Organization. Regional Office for Europe. https://iris.who.int/handle/10665/346420
Journal
Relation
Relation
Temporal Coverage
Statement of Responsibility
Description
viii, 35 p.
Table of Contents
Version
Sponsorship
PMID
PMCID
Document number
WHO/EURO:2019-3642-43401-60939
ISBN
ISSN
ISMN
Identifiers
Other Identifiers
Format
Language
English